Anal canal squamous-cell carcinomas in HIV positive patients: Clinical features, treatments and prognosis;Caractéristiques cliniques, thérapeutiques et pronostiques des carcinomes épidermoïdes du canal anal chez les malades VIH positifs

Gastroenterologie Clinique et Biologique

Volumn 26, Issue 2, 2002, Pages 150-156

  Vatra, Bogdan ^a   Sobhani, Iradj ^a   Aparicio, Thomas ^a   Girard, Pierre Marie ^b   Montbrun, Thierry DuPuy ^c   Housset, Martin ^d   Baillet, François ^e   Hecht, Franck ^a   Chossidow, Denis ^a   Soulé, Jean Claude ^a  

^a BICHAT HOSPITAL   (France)

^b HÔPITAL ROTHSCHILD   (France)

^c Léopold Bellan Hospital   (France)

^d HÔPITAL TENON   (France)

^e PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; FLUOROURACIL; MITOMYCIN C;

ADULT; AGED; ANUS CARCINOMA; ARTICLE; BLOOD TOXICITY; CANCER DIAGNOSIS; CANCER REGRESSION; CANCER STAGING; CANCER SURGERY; CLINICAL ARTICLE; CLINICAL FEATURE; DIARRHEA; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPH NODE METASTASIS; MALE; MORTALITY; MUCOSA INFLAMMATION; MULTIMODALITY CANCER THERAPY; POLYNEUROPATHY; PREVALENCE; PROGNOSIS; RECTUM FISTULA; RETROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; ANTINEOPLASTIC AGENTS; ANUS NEOPLASMS; CARCINOMA, SQUAMOUS CELL; FEMALE; HIV SEROPOSITIVITY; HOMOSEXUALITY; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; PROGNOSIS; RADIOTHERAPY; SURGICAL PROCEDURES, OPERATIVE; TREATMENT OUTCOME;

EID: 17544391882     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Les cancers de l'anus
2. Anal neoplasia. Pathogenesis, diagnosis, and management
3. High incidence of anal high-grade squamous intraepithelial lesions among HIV-positive and HIV-negative homosexual and bisexual men
4. HIV infection and genital warts as risk factors for anal intraepithelial neoplasia in homosexual men
5. Virologic, immunologic and clinical parameters in the incidence and progression of anal squamous intraepithelial lesions in HIV-positive and HIV-negative homosexual men
6. Prospective study of high grade anal squamous intraepithelial neoplasia in a cohort of homosexual men: Influence of HIV infection, immunosuppression and human papillomavirus infections
7. Sexually transmitted infection as a cause of anal cancer
8. Human papillomavirus infection in women infected with the human immunodeficiency virus
9. Prevalence and risk factors for human papillomavirus infection of the anal canal in human immunodeficiency (HIV)-positive and (HIV)-negative homosexual men
10. Anal human papillomavirus infection infection among homosexual and bisexual men: Prevalence of type-specific infection and association with HIV
11. Human papillomavirus infection and anogenital neoplasia in human immunodeficiency virus-positive men and women
12. Prevalence of high grade dysplasia and cancer in the anal canal in human papillomavirus-infected individuals
13. Carcinoma of the anal canal. A clinical and pathological study of 188 cases
14. Malignant epithelial tumors of the anal canal
15. Squamous carcinoma of the anus: A review of 96 cases
16. Results of surgical treatment of squamous cell carcinoma of the anal canal and anal margin seen at St Mark's Hospital 1928-66
17. Depth of invasion, location and size of cancer of the anus dictate operative treatment
18. Squamous cell carcinoma of the anus at one hospital from 1948 to 1984
19. Chemotherapy and radiation therapy for anal carcinoma. Survival and late morbidity
20. Results of combined modality therapy for patients with anal cancer (E7283). An Eastern Cooperative Oncology Group study
21. Chemoradiotherapy versus radiotherapy alone for anal cancer: A retrospective comparison
22. Epidermoid anal cancer: Treatment by radiation alone or by radiation and 5 fluorouracil with and without mitomycin C
23. Combined therapy for cancer of the anal canal: A follow-up report
24. Epidermoid carcinoma of the anal canal treatment results and prognostic variables in a series of 242 cases
25. Radiation (RT) and 5-fluorouracil (5 FU) vs. radiation, 5FU, mitomycine C (MMC) in the treatment of the anal carcinoma: Results of a phase III randomised RTOG/ECOG intergroup trial
26. Epidermoid anal cancer: Results from the United Kingdom Co-ordinating Committee on Cancer Research randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin
27. Concomitant radiotherapy and chemotherapy superior to radiotherapy alone in the treatment of locally advanced anal cancer: Results of a phase III randomised trial of the EORTC Radiotherapy and Gastrointestinal Co-operative Groups
28. Anal squamous intraepithelial lesions in HIV-positive and HIV-negative homosexual and bisexual men: Prevalence and risk factors
29. Anal cytology as a screening tool for anal squamous intraepithelial lesions
30. The clinical effectiveness and cost-effectiveness of screening for anal squamous intraepithelial lesions in homosexual and bisexual HIV-positive men
31. Squamous-cell carcinoma of the anus in HIV-positive patients
32. Tolerance of patients with human immunodeficiency virus and anal carcinoma to treatment with combined chemotherapy and radiation therapy
33. Squamous cell carcinoma of the anus and HIV infection
34. Squamous cell carcinoma of the anus in patients with AIDS
35. Squamous cell carcinomas of the anus and infection with human papillomavirus in patients with AIDS
36. Time-dose considerations in the treatment of anal cancer
37. Chemotherapy and low-dose radiotherapy in the treatment of HIV-infected patients with carcinoma of the anal canal
38. Epidermoid anal cancer in HIV infected patients
39. The significance of pre-treatment CD4 count on the outcome and treatment tolerance of HIV-positive patients with anal cancer
40. Low acute toxicity of radiotherapy and radiochemotherapy in patients with cancer of the anal canal and HIV-infection
41. Anal cancer in patients with HIV infection: A report of two cases without evidence of immunological dysfunction
42. Carcinoma of the anal canal in a patient with AIDS
43. Outcome analysis of HIV-positive patients with anal squamous cell carcinoma